Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World January 23, 2009 Ned Stafford	Outwitting the doping cheats of the future Biochemists at the German Sport University in Cologne have developed an anti-doping test for a drug candidate in early development that may counteract muscle fatigue and potentially enhance athletic performance.
American Family Physician November 1, 2000	Diabetes: Flexible Insulin Regimens for People with Type 1 Diabetes What is insulin?... How do I use insulin?... What is a flexible insulin regimen?... When should I take insulin?...
Chemistry World February 8, 2010 Rajendrani Mukhopadhyay	To catch a cheating athlete As the athletes take center stage at the Vancouver 2010 Winter Olympics and Paralympic Winter Games this month, chemists will be hard at work behind the scenes to catch athletes looking to win by taking drugs or blood products to artificially boost their performance during the competition.
American Family Physician July 15, 2006 Jennifer D. Goldman-Levine	Insulin Detemir (Levemir) for Diabetes Mellitus Insulin detemir is suitable as basal insulin in a basal-bolus regimen. In limited research, it has been shown to cause slightly fewer episodes of minor hypoglycemia and no weight gain in patients with type 1 and 2 diabetes, which is a benefit that must be balanced against its higher price.
Sports Illustrated August 3, 2000	IOC to target EPO dopers ...the International Olympic Committee will conduct tests for the cutting-edge performance enhancer erythropoietin...
Chemistry World February 23, 2006 Henry Nicholls	Mind-Altering Drugs at the Olympics As further evidence of performance-enhancing drug use at the Winter Olympics in Turin emerges, researchers have unveiled the first study to quantify the psychological effects of taking recombinant human erythropoietin (rHuEPO) on endurance athletes.
The Motley Fool August 12, 2005 Stephen D. Simpson	Novo Nordisk Perks Up This leading insulin company rebounds from a sluggish first quarter. For investors willing to buy and hold a stock for years, Novo Nordisk could still be an interesting play on a serious and growing disease market.
American Family Physician August 1, 2004	Your Insulin Therapy A patient guide to managing diabetes with insulin.
Chemistry World June 30, 2014 Phillip Broadwith	Inhaled insulin approved in US Mannkind's Affreza is aimed at reducing the need for patients to inject themselves with insulin so frequently.
American Family Physician August 1, 2004 Mayfield & White	Insulin Therapy for Type 2 Diabetes: Rescue, Augmentation, and Replacement of Beta-Cell Function New insulin preparations and a better understanding of insulin physiology provide more options for family physicians attempting to effectively tailor insulin therapy to the needs of individual patients.
Chemistry World April 8, 2014 Sarah Kenwright	Olive oil may offer diabetes protection Spanish scientists say increasing the amount of olive oil in your diet could reduce your risk of developing metabolic syndrome and type 2 diabetes.
American Family Physician March 15, 2001 Goutham Rao	Insulin Resistance Syndrome Insulin resistance can be linked to diabetes, hypertension, dyslipidemia, cardiovascular disease and other abnormalities. Because resistance usually develops long before these diseases appear, identifying and treating insulin-resistant patients has potentially great preventive value...
Nursing November 2009 Christine Kessler	Glycemic control in the hospital: How tight should it be? Based on recent studies, the answer to that question remains controversial. This article will explore this issue and present current best practices for caring for a patient in the hospital who has diabetes or hyperglycemia.
BusinessWeek June 14, 2004 Arlene Weintraub	Can Drug-Busters Beat New Steroids? Scientists enlisted by anti-doping agencies are trying to stay a step ahead of the cheaters as the Athens Olympics approach.
American Family Physician January 1, 2003 Jennifer B. Marks	Perioperative Management of Diabetes Diabetic patients who require surgery present special challenges in perioperative management. Special attention must be paid to prevention and treatment of metabolic derangements.
Nurse Practitioner May 2011 Stacey A. Seggelke	Hitting the target for inpatient glycemic management An understanding of glycemic treatment options for hospitalized patients is essential for good patient outcomes.
Outside July 2005 Brian Alexander	The Awful Truth About Drugs in Sports Drug-testing expert Don Catlin is the doping detective who helped break the BALCO scandal wide open- and the man who's about to launch a radical new campaign to finally solve the problem of drugs in sports.
Chemistry World July 2, 2012 Michael Stow	Protecting the spirit of competition With the London 2012 Olympics now upon us, the issue of doping in sport is once more in the media spotlight. As new therapies emerge from the pharmaceutical industry, we must be vigilant for new doping threats and new and improved detection methods are continually investigated and developed.
Chemistry World July 23, 2012 Jennifer Newton	Delivering insulin in a skin cream Scientists in Japan have developed a way to administer insulin to patients through the skin.
Food Processing August 2013 Mark Anthony	The Condemnation of Carbohydrates: A Food Manufacturers Guide to Understanding Diabetes The commonly held notion that sugar intake equals diabetes is a kind of unofficial dogma. But like many dogmas, this one falls apart upon closer examination.
American Family Physician March 15, 2001	Insulin Resistance Syndrome A simple overview of a condition that occurs for some people where tissues stop responding to insulin.
BusinessWeek December 22, 2003 Arlene Weintraub	Big Pharma Looks Beyond Insulin Researchers may be on the verge of major new treatments for diabetes and obesity.
Reason April 2007 Ronald Bailey	Testing Your Strength The World Anti-Doping Agency is developing tests for a form of cheating that doesn't exist yet. The agency banned gene doping, the alteration of genes to enhance athletic performance.
AskMen.com April 29, 2001 Joshua Levine	Do You Have Diabetes? Diabetes is not contagious; people cannot "catch" it from one another. However, certain factors can increase one's risk of developing the disease...
The Motley Fool July 27, 2007 Rich Duprey	Sniffing Out Bentley's New Patent To succeed in insulin therapy, the generic drugmaker must overcome patent expiration. Investors, take note.
American Family Physician May 1, 2005	Diabetic Ketoacidosis: What It Is and How to Prevent It An informative patient hand-out on the condition, its causes, triggers, prevention and instructions on what do if the conditions presents.
The Motley Fool October 27, 2005 Stephen D. Simpson	What's New With Novo? Novo Nordisk is a good play on diabetes, but will new drugs reduce the need for insulin? Investors, take note.
Managed Care December 2003 Thomas Morrow	Can Amylin Analogue Lead To Better Diabetes Control? Maintaining tight glucose control is difficult to accomplish, but adding amylin to the mix may be the answer.
Chemistry World August 23, 2013 Jessica Cocker	Plant protein regulates diabetes treatment A plant protein has been used to make a new class of glucose-responsive polymer nanogels that could one day negate the need for diabetes patients to constantly monitor their blood glucose levels and inject themselves with insulin.
The Motley Fool January 27, 2006 Stephen D. Simpson	Challenges Needle Novo Nordisk The insulin franchise is attractive, but under threat. Guidance for 2006 wasn't impressive and there are definite challenges ahead. Investors, take note.
Pharmaceutical Executive May 1, 2009	The Fate of Mannkind Al Mann has sunk almost $1 billion of his own money into a new insulin delivery system. Will FDA be persuaded?
The Motley Fool June 27, 2005 Stephen D. Simpson	Sniffing Out a Possible Diabetes Blockbuster Inhaled insulin has been a Holy Grail of diabetes care. Will it live up to lofty expectations? Pfizer, Sanofi-Aventis, and Lilly are all interesting in their own right as high-quality pharmaceutical companies, and more aggressive investors should take a look at Nektar and Alkermes, as well.
The Motley Fool June 29, 2009 Brian Orelli	Lantus Results: Reply Hazy, Try Again Later Drugmaker Sanofi's problems become murkier. Investors are relieved that the data is out -- Sanofi is up about 4.5% at the moment -- but it seems prudent to be cautious here.
Chemistry World November 9, 2010 Andrew Turley	Company snapshot: Novo Nordisk As the results for the third quarter of this year roll in, one pharma major - Danish company Novo Nordisk - seems to have done better than most with its diabetes medicines.
American Family Physician May 1, 2001	Treatment Options for Type 2 Diabetes -- What's Available? What are the different steps in managing my diabetes? What are the different types of medicines used to treat type 2 diabetes and how do they work?
Bio-IT World August 18, 2004 Mark D. Uehling	I, Virtual Patient Along with a software company specializing in modeling diseases on the computer, Roche Diagnostics is working on creating a new biomarker for diabetes that could be reduced to a simple blood test.
Managed Care October 2005 Thomas Morrow	Incretin Hormones Poised For Better Control of Diabetes Enhanced management continues due to a greater understanding of the intricate glucose balance and the shortfalls of existing medications.
The Motley Fool May 10, 2011 Brian Orelli	Waiting for MannKind's Pot of Gold It's going to be awhile.
HHMI Bulletin Fall 2012 Sarah C. P. Williams	The Fat You Can't See Without the liver acting as a filter and energy producer, a person can't survive, and no artificial organ can perform all of its duties. But in one in three Americans -- and similar numbers in other developed nations -- the liver has lost its luster.
The Motley Fool January 16, 2008 Brian Lawler	Another Inhalable Insulin Bites the Dust Novo Nordisk discontinues development of its troubled diabetes treatment and settles its patent infringement lawsuit against Pfizer. Investors, take note.
Pharmaceutical Executive March 1, 2006 Ron Feemster	Holding Their Breath: Inhaled Insulin Exubera, Pfizer's inhaled-insulin therapy, is carving out a new market for diabetes drugs. Four more companies are looking for their share.
IEEE Spectrum January 2011 Sandra Upson	Bionic Pancreas Artificial organ could improve control over diabetes
The Motley Fool April 28, 2005 Stephen D. Simpson	Novo Nordisk Could Use a Boost Investors reacted badly to first-quarter results, but there's still a lot to like about the Danish pharmaceutical.
Wired January 2007 Mark McClusky	The Righteous Fury of Dick Pound As head of the World Anti-Doping Agency, this man is on a crusade to rid elite sports of performance-enhancing drugs. And he's making a few enemies along the way.
The Motley Fool January 28, 2005 Stephen D. Simpson	An Understated Scandinavian The Danish pharmaceutical may not be quite cheap enough to be a true value, but investors looking for a solid growth stock should see what's new with Novo Nordisk.
The Motley Fool June 19, 2009 Robert Steyer	MannKind Needs More Leaps Getting FDA approval for its inhaled-insulin product is only one hurdle for this start-up pharmaceutical.
Managed Care April 2005	Diabetes Costs Rise, But so Does Adherence A typical health plan can expect endocrine and diabetes agents to amount to 6% to 8% of total utilization costs, with spending on these agents to increase between 11% and 15% 2005.
Managed Care May 2006 Fadia T. Shaya & Deshpande	New Treatment Approaches To Diabetes The goal of diabetes management is maintaining glycemic control while targeting quality of life improvements.
Salon.com January 22, 2001 Janet Lafler	I'm a cyborg and I love it My portable insulin pump never strays from my side, but I feel more human with the technology than without it...
American Family Physician September 15, 2006 Havas & Donner	Tight Control of Type 1 Diabetes: Recommendations for Patients Physicians play an important role in helping type 1 diabetes patients make essential lifestyle changes to help reduce the risk of microvascular and macrovascular complications.